| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.95▼ | 2.97▼ | 2.97▼ | 2.83▲ | 2.80▲ |
| MA10 | 2.96▼ | 2.99▼ | 2.98▼ | 2.72▲ | 2.85▲ |
| MA20 | 2.97▼ | 2.99▼ | 2.96▼ | 2.80▲ | 3.26▼ |
| MA50 | 2.98▼ | 2.91▲ | 2.78▲ | 2.94▲ | 3.81▼ |
| MA100 | 2.98▼ | 2.78▲ | 2.75▲ | 3.46▼ | 5.12▼ |
| MA200 | 2.97▼ | 2.76▲ | 2.84▲ | 3.88▼ | 6.51▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.012▼ | -0.012▼ | 0.039▲ | -0.009▼ |
| RSI | 34.940▼ | 46.689▼ | 55.397▲ | 56.381▲ | 42.976▼ |
| STOCH | 34.762 | 30.865 | 54.053 | 52.408 | 27.222 |
| WILL %R | -80.000▼ | -78.261▼ | -66.667 | -21.061▲ | -64.352 |
| CCI | -197.608▼ | -107.637▼ | -105.913▼ | 128.351▲ | -21.426 |
|
Monday, June 22, 2026 09:00 AM
The investment seeks to provide investment results that, before taking fees and expenses into account, match the positive price return of the Invesco QQQ TrustSM , Series 1 ("Underlying ETF") up to a ...
|
|
Wednesday, June 17, 2026 08:15 AM
Altimmune is trying to move pemvidutide into a larger Phase 3 study rather than leaving the program at mid-stage data. In its May 13 first-quarter update, the company said it expects to start the ...
|
|
Monday, May 04, 2026 05:00 PM
The investment seeks to provide investment results that, before taking fees and expenses into account, match the positive price return of the Invesco QQQ TrustSM , Series 1 up to a cap of 8.35, while ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/06/26 | 2.935 | 3.035 | 2.92 | 2.945 | 3,097,942 |
| 23/06/26 | 2.895 | 3.04 | 2.875 | 2.91 | 4,213,744 |
| 22/06/26 | 2.84 | 3.045 | 2.83 | 2.93 | 5,656,018 |
| 18/06/26 | 2.69 | 2.77 | 2.68 | 2.70 | 9,004,256 |
| 17/06/26 | 2.65 | 2.71 | 2.62 | 2.64 | 3,534,379 |
| 16/06/26 | 2.65 | 2.68 | 2.60 | 2.62 | 2,890,638 |
| 15/06/26 | 2.62 | 2.676 | 2.58 | 2.64 | 3,504,472 |
| 12/06/26 | 2.605 | 2.66 | 2.582 | 2.61 | 2,124,061 |
| 11/06/26 | 2.61 | 2.645 | 2.5702 | 2.59 | 3,396,131 |
| 10/06/26 | 2.62 | 2.705 | 2.605 | 2.61 | 3,021,425 |
|
|
||||
|
|
||||
|
|